GLP-1 agonists for weight loss: five things to know before you start.

What is a GLP-1 agonist?

GLP-1 (glucagon-like peptide-1) is a hormone your intestine releases within minutes of eating. It tells the pancreas to release insulin, tells the liver to hold back sugar, slows the stomach, and signals the brain that you've had enough. Then it's broken down in a few minutes.

An "agonist" is a drug that switches on a receptor the way the natural hormone does. A GLP-1 receptor agonist (sometimes written GLP-1 RA, or misspelled "GLP-1 agnonist" in searches) is a lab-made version engineered to resist that rapid breakdown. Instead of a few minutes, the newer ones last about a week, so fullness and lower hunger stay switched on between meals.

The class started as diabetes treatment in 2005. Researchers noticed patients consistently lost weight, and higher doses were then tested specifically for obesity. Today some GLP-1 medications are FDA-approved for chronic weight management, some for type 2 diabetes, and several carry approvals for reducing heart attack and stroke risk, sleep apnea or kidney disease in specific groups.

What it does in your body

• Brain: lowers hunger and the constant pull toward food.
• Stomach: empties more slowly, so you feel full on smaller portions.
• Pancreas: releases insulin when blood sugar is high, which is why, on its own, the risk of low blood sugar is small.
• Liver: less glucagon, so less sugar released after meals.

Which GLP-1 medications are there?

The names get confusing because one active ingredient can have several brand names for different uses and doses. Here are the main GLP-1-based medications in the U.S.:

Two of these work a little differently. Tirzepatide is a dual agonist: it activates the GLP-1 receptor and the receptor for a second gut hormone, GIP. Orforglipron is a small molecule rather than a peptide, which is why it can be swallowed with or without food, unlike the semaglutide tablet. For weight loss today, most conversations come down to semaglutide or tirzepatide.

Semaglutide vs tirzepatide: what's the difference?

Both are weekly injections taken with a reduced-calorie diet and more activity, both start low and step up every four weeks, and both share the same boxed warning about thyroid C-cell tumors in rodents. The differences are in how they work and how much weight people lost in trials.

On average, tirzepatide produced more weight loss. That doesn't make it the right choice for everyone. Some people respond very well to semaglutide, some tolerate one better than the other, some want a pill, and cost and availability differ. Side effects are similar in type: mostly nausea, diarrhea, constipation and vomiting, concentrated around dose increases.

Pens, vials or pills: how GLP-1s are taken

How you take your medication shapes your week as much as which molecule it is. These are the formats you're likely to see:

Compounded GLP-1 medications are usually supplied in vials. They are not FDA-approved. The FDA has received reports of dosing errors with compounded injectable semaglutide, some leading to hospital stays, when doses were measured incorrectly, and it has warned about counterfeit and illegally marketed versions. Whatever you use, you should know exactly what it is, who made it and how much is in each dose.

What to expect month by month

Everyone's timeline is a little different, but most people on a weekly GLP-1 move through roughly the same stages:

1. Weeks 1–4: getting used to it.The starting dose is a warm-up. Portions shrink and "food noise" quiets for many people. The scale may move only a little, and that's expected.
2. Months 2–4: stepping up.The dose rises every four weeks. Weight loss usually becomes steady. Most stomach side effects show up in the days after each increase, then settle.
3. Months 4–12: the main stretch.On a maintenance dose, this is when most weight is lost. Protein and strength training matter most here, to make sure the weight lost is fat and not muscle.
4. Around a year: the plateau.In trials, weight loss leveled off after about a year to 18 months. A plateau isn't failure; your body has found a new set point on the medication.
5. Long term: keeping it.When GLP-1s are stopped, appetite returns and many people regain much of the weight. The plan for this phase, whether staying on, lowering the dose or stopping, should be made with your provider.

Are GLP-1 agonists safe?

GLP-1 medications have been used in diabetes care for about two decades, and the large weight-loss and heart-outcome trials followed tens of thousands of people. For most, the trade-off is mainly temporary digestive side effects. There are real risks to know about, and a few people shouldn't take them at all.

• Not for you if you or a family member have had medullary thyroid carcinoma, you have MEN 2, or you've had a serious allergic reaction to the drug. They're stopped during pregnancy.
• Rare but serious: pancreatitis, gallbladder problems, kidney injury from dehydration, and severe allergic reactions.
• Before surgery: tell your surgical team, because a slow stomach can raise the risk of aspiration under anesthesia.

For the details, read our guides to semaglutide side effects and semaglutide contraindications.

Choosing the right GLP-1 at Regal

We don't start with a product. We start with you: your health history, labs, goals, routine, and how you feel about needles. After a free consultation, Eric Naifeh, FNP, PMHNP, DC, our Medical Director, evaluates you and prescribes a GLP-1 only when it's clinically appropriate. That might be semaglutide or tirzepatide, as a weekly injection or a daily pill, and your provider explains exactly which product you're getting and why.

From there, the medication is paired with a nutrition plan and weekly check-ins with your consultant, who tracks your progress and side effects and keeps dose steps on schedule. Want more on the program itself? Read about GLP-1 weight loss at Regal.